Bypass Versus Interwoven Nitinol Stents for Long Femoro-Popliteal Occlusions: A Propensity Matched Analysis
- 17 May 2022
- journal article
- research article
- Published by Springer Nature in CardioVascular and Interventional Radiology
- Vol. 45 (7) , 929-938
Abstract
Purpose To compare femoro-popliteal bypass and interwoven nitinol stenting for long occlusions of the femoro-popliteal segment. Materials and Methods Single center retrospective propensity matching analysis of the symptomatic patients with long occlusion of the femoro-popliteal segment (> 20 cm), who underwent stenting with interwoven nitinol stent or femoro-popliteal bypass from 2012 to 2020. Primary endpoints: primary patency, primary-assisted patency, secondary patency. Secondary endpoints: major adverse cardiovascular events, major adverse limb events, primary sustained clinical improvement, survival. Results A total of 437 patients were enrolled: 294 in the bypass group and 143 in the endovascular therapy (EVT) group. After propensity score matching, 264 and 113 patients remained in the groups, respectively. A median occlusion length was 250 mm. One-year and two-year primary and secondary patency rates were comparable in both groups (two-year primary patency: 68.5% for bypass vs. 68.9% for EVT, p = 1.00). In the “above the knee” subgroup analysis, two-year secondary patency was higher in the EVT group than in the bypass group (90.9% vs. 77.5%, p = 0.048). In “below-the-knee” subgroup analysis, primary and primary assisted patency were statistically significantly higher in the EVT group than in artificial bypass subgroup (66.7% vs. 42.4%, p = .046 and 76.7% vs. 45.5%, p = .011, respectively). However, compared to autovenous bypass, the EVT group showed lower primary patency rates, although the differences are not significant. Conclusion A nonselective endovascular strategy can allow for regular successful treatment of femoro-popliteal lesions longer than 25 cm.Keywords
This publication has 14 references indexed in Scilit:
- 2017 ESC Guidelines on the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS)European Heart Journal, 2017
- An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee ArteriesJournal of Endovascular Therapy, 2015
- Stent Fractures After Superficial Femoral Artery StentingJournal of Endovascular Therapy, 2015
- Sustained Benefit at 2 Years for Covered Stents Versus Bare-Metal Stents in Long SFA Lesions: The VIASTAR TrialCardioVascular and Interventional Radiology, 2014
- Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registryEuroIntervention, 2014
- Comparison of Long-Term Outcome After Endovascular Therapy Versus Bypass Surgery in Claudication Patients With Trans-Atlantic Inter-Society Consensus-II C and D Femoropopliteal DiseaseCirculation Journal, 2014
- Nitinol Stent Implantation vs. Balloon Angioplasty for Lesions in the Superficial Femoral and Proximal Popliteal Arteries of Patients With Claudication: Three-Year Follow-up From the RESILIENT Randomized TrialJournal of Endovascular Therapy, 2012
- Using high‐dimensional propensity scores to automate confounding control in a distributed medical product safety surveillance systemPharmacoepidemiology and Drug Safety, 2012
- Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)European Journal of Vascular and Endovascular Surgery, 2007
- Drug-Eluting and Bare Nitinol Stents for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery:Long-term Results From the SIROCCO TrialJournal of Endovascular Therapy, 2006